Skip to main content

Table 1 Demographic and clinical characteristics of healthy controls and PD patients

From: Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study

Cohort

Gender

(M/F)

Age

(years)

Duration of disease (years)

UPDRS

PDRP Z-score

Preoperative baseline

Post-operation

Preoperative baseline

Post-operation

3 months

12 months

3 months

12 months

Cohort I

HC1

15/18

57.4 ± 10.5

0 ± 1.0

PD1

15/18

58.1 ± 10.3

4.3 ± 4.1

25.2 ± 14.4

2.74 ± 1.18

Cohort II

HC2

4/5

61.7 ± 7.3

0 ± 0.52

PD2 (patients underwent DBS)

1

F

50

8

49

21

60

3.01

0.11

1.83

2

M

66

19

62

53

69

1.61

− 0.18

0.17

3

M

62

10

51

10

37

2.42

1.97

2.28

4

F

72

5

50

12

31

1.52

− 0.40

0.39

5

M

53

17

39

30

4.21

2.84

6

F

54

13

52

31

2.89

2.77

7

F

77

7

51

24

3.71

2.53

8

F

69

4

58

56

2.69

2.11

9

M

65

6

35

10

0.72

0.26

Total

4/5

63.1 ± 9.2

9.9 ± 5.3

49.7 ± 8.4

27.4 ± 17.3

49.3 ± 18.2

2.53 ± 1.11

1.33 ± 1.35

1.17 ± 1.04

  1. Data are given as mean ± standard deviation
  2. UPDRS Unified Parkinson’s Disease Rating Scale